Autonomy Securities Litigation: First Section 90A Quantum Decision

On 22 July 2025, Mr Justice Hildyard handed down the long-awaited quantum judgment in ACL Netherlands B.V. v Michael Richard Lynch [2025] EWHC 1877 (Ch), concluding one of the UK's most significant fraud trials. The judgment awards HP entities £646 million under Section 90A of the Financial Services and Markets Act 2000 (“FSMA”), representing the first quantum determination in a Section 90A claim to proceed to trial.

The quantum phase, delayed following the death of Dr Michael Lynch in August 2024, required complex valuation exercises to determine what HP would have paid for Autonomy had accurate financial information been disclosed.

Background

HP's US$11.1 billion acquisition of Autonomy Corporation in 2011 represented one of the largest technology deals of its time. Autonomy, led by CEO Dr Michael Lynch and CFO Sushovan Hussain, was marketed as a high-growth software company specialising in unstructured data analysis through its IDOL technology platform.

The liability judgment

In May 2022, Mr Justice Hildyard delivered a comprehensive liability judgment finding that Autonomy had engaged in systematic accounting fraud designed to inflate its financial performance. The court established that Dr Lynch and Mr Hussain orchestrated a scheme involving:

• Autonomy improperly classified loss-making hardware sales (totalling $202.7 million) as software revenues to inflate margins and growth rates. These transactions were economically irrational, undertaken solely for accounting purposes.
• The defendants created artificial revenue acceleration through contrived value added reseller (“VAR”) transactions, including arrangements where Autonomy would pay substantial “marketing assistance fees” to channel partners who would then purchase Autonomy software, effectively creating circular cash flows.
• Autonomy entered into reciprocal arrangements where it would purchase goods or services from customers who simultaneously bought Autonomy software, with no genuine commercial substance to either side of the transaction.
• Autonomy manipulated existing hosting arrangements to accelerate revenue recognition, often at substantial long-term cost to the business.

The court therefore concluded that had HP known Autonomy's true financial position, it would not have proceeded with the acquisition at the £25.50 per share bid price. For a detailed analysis of the liability judgment and its implications for Section 90A FSMA claims, see our previous article: Securities litigation – cometh the hour!.

The quantum assessment

The FSMA counterfactual framework

The quantum hearing, conducted over eight days in February 2024, required the court to undertake a sophisticated “FSMA Counterfactual” analysis. This involved determining what HP would have been willing to pay in a hypothetical world where Autonomy had always disclosed its true financial position accurately.

Mr Justice Hildyard emphasised the inherently subjective nature of this exercise, noting that company valuations in takeover contexts depend not on intrinsic value but on what specific bidders are prepared to pay. The court applied what it termed a “broad axe” or “broad brush” approach, acknowledging that precise quantification was impossible given the hypothetical nature of the analysis.

Expert valuation disputes

The quantum hearing featured extensive expert evidence from rival valuation specialists:

• HP's expert (Mr Bezant) adopted a comprehensive discounted cash flow approach, arguing that revelation of Autonomy's true position would have fundamentally altered HP's valuation methodology. His approach involved:
  • Reducing the terminal growth rate from 4% to 3.5% based on Autonomy's revealed weaker software performance.
  • Applying mechanical percentage reductions to synergy valuations proportionate to standalone value decreases.
  • Arguing that the absence of genuine OEM business demonstrated that “Autonomy's technology was less attractive and not as widely adopted as had appeared”.
• Concluding that these factors would cascade through HP's entire valuation framework.
• Defendants' expert (Mr Giles) fundamentally challenged this methodology, contending that:
  • Stripping out fraudulent transactions would have revealed a “leaner but more efficient business” with higher gross margins and enhanced cash conversion.
  • The underlying IDOL technology remained genuinely valuable and market-leading.
  • HP's strategic imperatives and synergy calculations would not have been materially affected by accounting adjustments.
  • The same 4% terminal growth rate should apply as HP would still have viewed Autonomy as operating in “hyper-growth sectors”.

The court's analysis therefore revealed that the experts' $3 billion valuation gap stemmed not from minor parameter disagreements but from diametrically opposed views on whether accounting fraud impacts underlying business fundamentals in discounted cash flow valuations.

HP’s conflicting counterfactuals

A significant issue arose regarding HP's approach to different categories of shares within the transaction. HP had sought to argue that for 92.6% of Autonomy's shares (FSMA claim) the transaction would have proceeded at a lower price, while for 7.4% of shares held by defendants (misrepresentation/deceit claims) the transaction would not have proceeded at all. Mr Justice Hildyard firmly rejected this approach, finding that the same factual scenario must apply to the entire transaction.

The court's valuation conclusion

After extensive analysis, Mr Justice Hildyard concluded that in the FSMA Counterfactual, HP would have agreed to acquire Autonomy at £23.00 per share, compared to the actual £25.50 per share price. This determination reflected several key findings:

The court found that HP was seeking transformational change through acquisition. Having focused exclusively on Autonomy as the best available target, HP would have remained “enthusiastic and (within reason) determined” to complete the acquisition even with knowledge of the true financial position.

 The judgment recognised Dr Lynch as an “exceptionally persuasive negotiator” who would have held “the higher ground” in counterfactual negotiations, limiting the discount HP could have achieved.

 HP's anticipated synergies from the acquisition would have remained largely intact in the counterfactual scenario, supporting a premium above standalone value.

Despite its accounting irregularities, Autonomy possessed genuinely valuable “world-beating” IDOL technology that “opened up analysis the then uncharted but vast area of unstructured data”.

Financial awards

Primary FSMA claim

The court awarded £646,178,248 under the Section 90A FSMA claim, representing 92.6% of Autonomy's share capital. This calculation was reached by applying the £2.50 per share difference (£25.50 actual price minus £23.00 counterfactual price) across the relevant shareholding.

The court determined that the primary FSMA award of £646,178,248 should be converted to US dollars (as HP's “plaintiff's currency”), but deferred the final calculation pending further submissions on exchange rates and timing of crystallisation.

HP accepted that they must provide credit for a $45 million settlement recovered from Autonomy's auditors.

Misrepresentation claims

Additional awards totalling £51,698,505 were made under common law misrepresentation and deceit claims against Dr Lynch and Mr Hussain personally, relating to their respective shareholdings.

Direct loss claims

While the claimants sought approximately $76.1 million across four categories (hardware losses, VAR marketing assistance fees, reciprocal transactions, and hosting contract restructurings), the court's final awards totalled approximately $55.7 million:

• ASL (Third Claimant): $7,557,510 sterling equivalent against both Dr Lynch and Mr Hussain jointly and severally.
• Autonomy Inc (Fourth Claimant): $38,776,876 in US dollars against both Dr Lynch and Mr Hussain jointly and severally.
• Autonomy Inc (Fourth Claimant): $9,412,000 in US dollars against Mr Hussain only (for assigned Zantaz claims).

The court notably rejected most of the claimed hosting transaction losses, awarding only $5 million instead of the approximately $25 million sought, stating it was “discounting the Claimants' calculation by a little more than 75% to reflect the inherent uncertainties”.

Conclusion

The Autonomy quantum judgment provides the most comprehensive judicial analysis to date of damages assessment in Section 90A FSMA claims. However, it should be acknowledged that the specific methodology applied may have limited applicability beyond acquisition-related securities claims.

The court's approach was fundamentally shaped by its corporate acquisition context, which may not necessarily translate to other Section 90A claims. For example, claims arising from share price drops following misleading reports may require different approaches, such as event study analysis or trading-based models.

While the specific methodology may not universally apply, several broader principles from this judgment retain general precedential value. For institutions, the judgment serves as both a warning about the consequences of inadequate disclosure and a reassurance that damages will be assessed realistically rather than punitively.

As the first Section 90A quantum judgment to proceed to trial, this decision will undoubtedly serve as a key reference point for those with an interest in securities litigation.

For a copy of the judgment please click here.